Johnson Investment Counsel’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Johnson Investment Counsel’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-634	Closed	-$201K	–	791
2023 Q4	$201K	Buy	+634	New	+$123K	﹤0.01%	682

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Johnson Investment Counsel's KRTX Position: Q1 2024 in Review

Johnson Investment Counsel sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 634 shares — an estimated $201K sold.

Johnson Investment Counsel first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $201K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Johnson Investment Counsel reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Johnson Investment Counsel sold 634 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $201K.
Johnson Investment Counsel first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Johnson Investment Counsel's Karuna Therapeutics, Inc. Common Stock position peaked at $201K in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Johnson Investment Counsel's 13F filing for Q1 2024, filed 9 May 2024.